Glycopyrronium	glycopyrronium	O	O	OTHERS	I
requirements	requirements	O	O	O	O
for	for	O	O	O	O
antagonism	antagonism	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
muscarinic	muscarinic	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
edrophonium	edrophonium	O	O	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
have	have	O	O	O	O
compared	compared	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
60	60	O	O	O	O
adult	adult	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
glycopyrronium	glycopyrronium	O	O	OTHERS	I
5	5	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
and	and	O	O	O	O
10	10	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
given	given	O	O	O	O
either	either	O	O	O	O
simultaneously	simultaneously	O	O	O	O
or	or	O	O	O	O
1	1	O	O	O	O
min	min	O	O	O	O
before	before	O	O	O	O
edrophonium	edrophonium	O	O	OTHERS	I
1	1	O	O	O	O
mg	mg	O	O	OTHERS	I
kg-1	kg-1	O	O	O	O
.	.	O	O	O	O

Significant	significant	O	O	O	O
differences	differences	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
four	four	O	O	O	O
groups	groups	O	O	O	O
were	were	O	O	O	O
detected	detected	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Both	both	O	O	O	O
groups	groups	O	O	O	O
receiving	receiving	O	O	O	O
10	10	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
showed	showed	O	O	O	O
increases	increases	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
up	up	O	O	O	O
to	to	O	O	O	O
30	30	O	O	O	O
beat	beat	O	O	O	O
min-1	min-1	O	O	O	O
(	(	O	O	O	O
95	95	O	O	O	O
%	%	O	O	O	O
confidence	confidence	O	O	O	O
limits	limits	O	O	O	O
28	28	O	O	O	O
-	-	O	O	O	O
32	32	O	O	O	O
beat	beat	O	O	O	O
min-1	min-1	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Use	use	O	O	O	O
of	of	O	O	O	O
glycopyrronium	glycopyrronium	O	O	OTHERS	I
5	5	O	O	O	O
micrograms	micrograms	O	O	O	O
kg-1	kg-1	O	O	O	O
provided	provided	O	O	O	O
greater	greater	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
stability	stability	O	O	O	O
and	and	O	O	O	O
,	,	O	O	O	O
given	given	O	O	O	O
1	1	O	O	O	O
min	min	O	O	O	O
before	before	O	O	O	O
the	the	O	O	O	O
edrophonium	edrophonium	O	O	OTHERS	I
,	,	O	O	O	O
was	was	O	O	O	O
sufficient	sufficient	O	O	O	O
to	to	O	O	O	O
minimize	minimize	O	O	O	O
early	early	O	O	O	O
,	,	O	O	O	O
edrophonium-induced	edrophonium-induced	O	O	O	O
bradycardias	bradycardias	O	O	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
low	low	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
glycopyrronium	glycopyrronium	O	O	OTHERS	I
provided	provided	O	O	O	O
good	good	O	O	O	O
control	control	O	O	O	O
of	of	O	O	O	O
oropharyngeal	oropharyngeal	O	O	O	O
secretions	secretions	O	O	O	O
.	.	O	O	O	O

